Kite Founder Jakobovits Raises $51m For Off-The-Shelf Startup Adicet; Aprecia Prints $35m

Add Adicet Bio Inc. to the long and growing list of private biotechnology firms raising venture capital in January, proving that the industry is able to attract investors despite declining stock values for publicly traded drug development companies.

Add Adicet Bio Inc. to the long and growing list of private biotechnology firms raising venture capital in January, proving that the industry is able to attract investors despite declining stock values for publicly traded drug development companies.

Menlo Park, California-based Adicet raised $51m in a Series A round to fund development of off-the-shelf cell therapies for cancer...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category